225 related articles for article (PubMed ID: 31703596)
1. Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion.
Minopoli M; Botti G; Gigantino V; Ragone C; Sarno S; Motti ML; Scognamiglio G; Greggi S; Scaffa C; Roca MS; Stoppelli MP; Ciliberto G; Losito NS; Carriero MV
J Exp Clin Cancer Res; 2019 Nov; 38(1):459. PubMed ID: 31703596
[TBL] [Abstract][Full Text] [Related]
2. Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells.
Ragone C; Minopoli M; Ingangi V; Botti G; Fratangelo F; Pessi A; Stoppelli MP; Ascierto PA; Ciliberto G; Motti ML; Carriero MV
J Exp Clin Cancer Res; 2017 Dec; 36(1):180. PubMed ID: 29216889
[TBL] [Abstract][Full Text] [Related]
3. Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity.
Minopoli M; Polo A; Ragone C; Ingangi V; Ciliberto G; Pessi A; Sarno S; Budillon A; Costantini S; Carriero MV
Sci Rep; 2019 Aug; 9(1):12169. PubMed ID: 31434916
[TBL] [Abstract][Full Text] [Related]
4. Formyl peptide receptor 2 expression predicts poor prognosis and promotes invasion and metastasis in epithelial ovarian cancer.
Xie X; Yang M; Ding Y; Yu L; Chen J
Oncol Rep; 2017 Dec; 38(6):3297-3308. PubMed ID: 29039544
[TBL] [Abstract][Full Text] [Related]
5. Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.
Yousif AM; Minopoli M; Bifulco K; Ingangi V; Di Carluccio G; Merlino F; Motti ML; Grieco P; Carriero MV
PLoS One; 2015; 10(5):e0126172. PubMed ID: 25938482
[TBL] [Abstract][Full Text] [Related]
6. Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients.
Wang L; Madigan MC; Chen H; Liu F; Patterson KI; Beretov J; O'Brien PM; Li Y
Gynecol Oncol; 2009 Aug; 114(2):265-72. PubMed ID: 19450871
[TBL] [Abstract][Full Text] [Related]
7. Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.
Carriero MV; Bifulco K; Ingangi V; Costantini S; Botti G; Ragone C; Minopoli M; Motti ML; Rea D; Scognamiglio G; Botti G; Arra C; Ciliberto G; Pessi A
Sci Rep; 2017 May; 7(1):1312. PubMed ID: 28465589
[TBL] [Abstract][Full Text] [Related]
8. Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration.
Yousif AM; Ingangi V; Merlino F; Brancaccio D; Minopoli M; Bellavita R; Novellino E; Carriero MV; Carotenuto A; Grieco P
Eur J Med Chem; 2018 Jan; 143():348-360. PubMed ID: 29202399
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of the N-formyl Peptide receptors in scleroderma fibroblasts fosters the switch to myofibroblasts.
Rossi FW; Napolitano F; Pesapane A; Mascolo M; Staibano S; Matucci-Cerinic M; Guiducci S; Ragno P; di Spigna G; Postiglione L; Marone G; Montuori N; de Paulis A
J Immunol; 2015 Jun; 194(11):5161-73. PubMed ID: 25917089
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide.
Gargiulo L; Longanesi-Cattani I; Bifulco K; Franco P; Raiola R; Campiglia P; Grieco P; Peluso G; Stoppelli MP; Carriero MV
J Biol Chem; 2005 Jul; 280(26):25225-32. PubMed ID: 15866865
[TBL] [Abstract][Full Text] [Related]
11. HDAC1/2 control mesothelium/ovarian cancer adhesive interactions impacting on Talin-1-α5β1-integrin-mediated actin cytoskeleton and extracellular matrix protein remodeling.
Terri M; Sandoval P; Bontempi G; Montaldo C; Tomero-Sanz H; de Turris V; Trionfetti F; Pascual-Antón L; Clares-Pedrero I; Battistelli C; Valente S; Zwergel C; Mai A; Rosanò L; Del Pozo MÁ; Sánchez-Álvarez M; Cabañas C; Tripodi M; López-Cabrera M; Strippoli R
J Exp Clin Cancer Res; 2024 Jan; 43(1):27. PubMed ID: 38254102
[TBL] [Abstract][Full Text] [Related]
12. Mesothelium expression of vascular cell adhesion molecule-1 (VCAM-1) is associated with an unfavorable prognosis in epithelial ovarian cancer (EOC).
Scalici JM; Arapovic S; Saks EJ; Atkins KA; Petroni G; Duska LR; Slack-Davis JK
Cancer; 2017 May; 123(6):977-984. PubMed ID: 28263384
[TBL] [Abstract][Full Text] [Related]
13. Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro.
Heyman L; Kellouche S; Fernandes J; Dutoit S; Poulain L; Carreiras F
Tumour Biol; 2008; 29(4):231-44. PubMed ID: 18781095
[TBL] [Abstract][Full Text] [Related]
14. The urokinase receptor takes control of cell migration by recruiting integrins and FPR1 on the cell surface.
Gorrasi A; Li Santi A; Amodio G; Alfano D; Remondelli P; Montuori N; Ragno P
PLoS One; 2014; 9(1):e86352. PubMed ID: 24466048
[TBL] [Abstract][Full Text] [Related]
15. Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion.
Bifulco K; Longanesi-Cattani I; Franco P; Pavone V; Mugione P; Di Carluccio G; Masucci MT; Arra C; Pirozzi G; Stoppelli MP; Carriero MV
PLoS One; 2012; 7(9):e44806. PubMed ID: 23049759
[TBL] [Abstract][Full Text] [Related]
16. Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and -like 2.
de Paulis A; Montuori N; Prevete N; Fiorentino I; Rossi FW; Visconte V; Rossi G; Marone G; Ragno P
J Immunol; 2004 Nov; 173(9):5739-48. PubMed ID: 15494526
[TBL] [Abstract][Full Text] [Related]
17. Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1.
Liu FC; Yu HP; Syu YT; Fang JY; Lin CF; Chang SH; Lee YT; Hwang TL
Sci Rep; 2017 Jul; 7(1):6718. PubMed ID: 28751674
[TBL] [Abstract][Full Text] [Related]
18. Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence.
Bifulco K; Votta G; Ingangi V; Di Carluccio G; Rea D; Losito S; Montuori N; Ragno P; Stoppelli MP; Arra C; Carriero MV
Oncotarget; 2014 Jun; 5(12):4154-69. PubMed ID: 24980826
[TBL] [Abstract][Full Text] [Related]
19. FPR2 participates in epithelial ovarian cancer (EOC) progression through RhoA-mediated M2 macrophage polarization.
Xie X; He J; Wang Q; Liu Y; Chen W; Shi K
J Ovarian Res; 2021 Dec; 14(1):177. PubMed ID: 34930387
[TBL] [Abstract][Full Text] [Related]
20. The Expression of Formyl Peptide Receptor 1 is Correlated with Tumor Invasion of Human Colorectal Cancer.
Li SQ; Su N; Gong P; Zhang HB; Liu J; Wang D; Sun YP; Zhang Y; Qian F; Zhao B; Yu Y; Ye RD
Sci Rep; 2017 Jul; 7(1):5918. PubMed ID: 28724995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
